ArticleNature immunology2021

Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma.

Nicolas Jacquelot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.